Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 901–1,000 of 1,001
Personalized Pharmacotherapy for Treatment Approaches Focused at Primary Insomnia
Smith, H. S., Barkin, R. L., & Barkin, S. J. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182012fb4 · Cited by 8
Closing the Gap Between the Molecular and Systemic Actions of Anesthetic Agents
Antkowiak, B. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.009 · Cited by 8
Ion channels — a plethora of pharmaceutical targets
Vandenberg, J. I., & Lummis, S. C. R. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01558-3 · Cited by 8
Toolika, E., Ravi, M., Narayana Prakash, B., Shetty, S. K., Ravishankar, B., & Savitha, H. (2015) · The Journal of Phytopharmacology · doi:10.31254/phyto.2015.4304 · Cited by 8
Assessment of GABAABenzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence
Taylor, C., Nash, J. R., Rich, A. S., Lingford-Hughes, A. R., Nutt, D., & Potokar, J. P. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn056 · Cited by 8
Rudolph, U. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.33 · Cited by 8
Self-citationα-Subunit selective modulators of GABAAreceptor function as CNS therapeutics
Hamilton, N. M., & Cooke, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1491 · Cited by 8
Shultz, P. L., Galler, J. R., & Tonkiss, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00907-3 · Cited by 8
Troppoli, T. A., & Thompson, S. M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.036 · Cited by 7
Topically applied caffeine induces miosis in the ketamine/xylazine anesthetized rat
Kronschläger, M., Yu, Z., Talebizadeh, N., Meyer, L. M., & Söderberg, P. G. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.07.023 · Cited by 7
Excitation–Inhibition Epilepsies
Thomas, A. X., & Brooks‐Kayal, A. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00042-x · Cited by 7
Guerrini, G., Ciciani, G., Crocetti, L., Daniele, S., Ghelardini, C., Giovannoni, M. P., Mannelli, L. D. C., Martini, C., & Vergelli, C. (2017) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2882 · Cited by 7
Mild chronic perturbation of inhibition severely alters hippocampal function
Sun, M.-Y., Ziolkowski, L. H., Lambert, P. M., Shu, H.-J., Keiser, M., Rensing, N. R., Warikoo, N., Martinek, M., Platnick, C., Benz, A. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52851-w · Cited by 7
Liu, J., Liu, X., Zhou, W.-Y., Gan, J., Wang, J., Zhang, Q., Li, J.-L., Shen, Z.-S., Zhang, Y., Tang, Q., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1153735 · Cited by 7
Ren, Y., Xie, R., Marshall, S. F., Li, L., Zhou, T., & Lu, W. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1918-8 · Cited by 7
Hintermann, S., Hurth, K., Nozulak, J., Tintelnot‐Blomley, M., Aichholz, R., Blanz, J., Kaupmann, K., & Mosbacher, J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.107 · Cited by 7
Over-expression of δC-DCLK-short in mouse brain results in a more anxious behavioral phenotype
Schenk, G. J., Veldhuisen, B., Wedemeier, O., McGown, C. C., Schouten, T. G., Oitzl, M. S., de Kloet, E. R., & Vreugdenhil, E. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.08.002 · Cited by 7
Pharmacophore models for GABAAmodulators: implications in CNS drug discovery
Ghoshal, N., & Vijayan, R. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003789363 · Cited by 7
Absorption, excretion, and metabolism of a potential GABA-Aα2/3receptor modulator in rats
Guo, J. P., Davis, P. C., Gu, C., & Grimm, S. W. (2011) · Xenobiotica · doi:10.3109/00498254.2010.545453 · Cited by 7
Kim, J., Atherley, R. J., Werner, D. F., Homanics, G. E., Carstens, E. E., & Antognini, J. F. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.057 · Cited by 7
Analysis of Differential Efficacy and Affinity of GABAA(α1/α2) Selective Modulators
Ain, Q. U., Owen, R. M., Omoto, K., Torella, R., Bulusu, K. C., Pryde, D. C., Glen, R. C., Fuchs, J. E., & Bender, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00813 · Cited by 7
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands
Pandey, K. P., Khan, M. Z. A., Golani, L. K., Mondal, P., Mian, M. Y., Rashid, F., Tiruveedhula, V. V. N. P. B., Knutson, D. E., Sharmin, D., Ahmed, T., et al. (2020) · ARKIVOC · doi:10.24820/ark.5550190.p011.398 · Cited by 7
Attaining in vivo selectivity of positive modulation of α3βγ2 GABAA receptors in rats: A hard task!
Batinić, B., Stanković, T., Stephen, M. R., Kodali, R., Tiruveedhula, V. V. N. P. B., Li, G., Scholze, P., Marković, B. D., Obradović, A. L., Ernst, M. C., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.014 · Cited by 7
Gene-edited CRISPy Critters for alcohol research
Homanics, G. E. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.03.001 · Cited by 7
Pickering, C., Bergenheim, V., Schiöth, H. B., & Ericson, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.011 · Cited by 7
Pearce, R. A., Duscher, P., Dyke, K. V., Lee, M., Andrei, A., & Perouansky, M. A. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aer451 · Cited by 7
Sleeping through the night: Are extended‐release formulations the answer?
Calamaro, C. (2008) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2007.00279.x · Cited by 7
Xue, L., Li, L., Hsieh, J. Y. ‐., & Matuszewski, B. K. (2004) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-120028257 · Cited by 7
Receptor Targets in Drug Discovery and Development
Williams, M. J., Mehlin, C., & Triggle, D. J. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc029 · Cited by 7
Hamilton, K. E., Shelton, C. M., Wheless, J. W., & Phelps, S. J. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.4.320 · Cited by 6
Warlick, H., Leon, L., Patel, R., Filoramo, S., Knipe, R., Joubran, E., Levy, A., Nguyen, H., & Rey, J. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08110-9 · Cited by 6
Szabó, G., Károlyi, B. I., Vaskó, Á. G., Potor, A., Vukics, K., Kapus, G. L., Fodor, L., Bobok, A. Á., Vastag, M., & Bata, I. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00608 · Cited by 6
Rahman, S. U., Rehman, N. U., Aschner, M., & Khan, H. Z. (2023) · Phytonutrients · doi:10.62368/pn.vi.19 · Cited by 6
Krogsgaard‐Larsen, P., Frølund, B., & Liljefors, T. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(06)54003-7 · Cited by 6
Georgopoulos, P., Petrides, T., Kostopoulos, G., & Papatheodoropoulos, C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.017 · Cited by 6
Rinaldi, D., Larrigaldie, V., Chapouthier, G., & Martin, B. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00293-5 · Cited by 6
Ligand-Gated Pentameric ion Channels, from Binding to Gating
Maksay, G. (2009) · Current Molecular Pharmacology · doi:10.2174/1874-470210902030253 · Cited by 6
Leppä, E., Linden, A.-M., Rabe, H., Vekovischeva, O. Y., Wulff, P., Lüddens, H., Wisden, W., & Korpi, E. R. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.011 · Cited by 6
Memory Impairment after Drug-Facilitated Crimes
Saussereau, É., Guerbet, M., Anger, J.-P., & Goullé, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416748-3.00005-0 · Cited by 6
Karkischenko, N. N., Karkischenko, V. N., Fokin, Y. V., Taboyakova, L. A., Алимкина, О. В., & Борисова, М. М. (2020) · Journal Biomed · doi:10.33647/2074-5982-16-2-12-38 · Cited by 6
Jembrek, M. J., Vlainić, J., & Šuran, J. (2015) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2015-2025 · Cited by 6
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 6
Chaytor, A. T. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.61585-5 · Cited by 6
Pharmacology of Intravenous Anesthetics
García, P. S., Whalin, M. K., & Sebel, P. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00010-7 · Cited by 6
General Anesthetic Effects on GABAA Receptors
Pearce, R. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-322-4_16 · Cited by 6
Underreporting of Conversion from Off-pump Coronary Artery Bypass Surgery
Zangrillo, A., Annalisa, F., Crescenzi, G., Pappalardo, F., Boroli, F., Sottocorna, O., & Landoni, G. (2005) · Anesthesiology · doi:10.1097/00000542-200510000-00037 · Cited by 6
GABAA Receptor Subtypes: Memory Function and Neurological Disorders
Fritschy, J., Crestani, F., Rudolph, U., & Möhler, H. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0039-1_14 · Cited by 6
Self-citationSynaptic correlates of benzodiazepine tolerance
Piot, A., & Jovanovic, J. N. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03512-8 · Cited by 5
Singh, S., Kaira, M., Dey, H., Pandey, K. C., Tahlan, S., & Singh, K. (2024) · ChemistrySelect · doi:10.1002/slct.202404350 · Cited by 5
The effects of diazepam on sleep depend on the photoperiod
Panagiotou, M., Meijer, J. H., & Deboer, T. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01440-3 · Cited by 5
Fuhr, A., Roediger, R. L., Simelitidis, M., Gamper‐Tsigaras, J., Templin, M. F., Kormann, M., Antkowiak, B., Rudolph, U., Köhler, D., Rosenberger, P., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07488-1 · Cited by 5
Self-citationLewter, L. A., Golani, L. K., Cook, J. M., & Li, J. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000614 · Cited by 5
Modulation of sleep/wake patterns by gephyrin phosphorylation status
Tsai, Y., ElGrawani, W., Muheim, C., Spinnler, A., Campbell, B. F. N., Lasic, D., Hleihil, M., Brown, S. A., & Tyagarajan, S. K. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16464 · Cited by 5
Lewis, R. W., Hess, G. P., & Ganem, B. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.10.302 · Cited by 5
Complex Behaviors Related to Zolpidem: An Analysis of Published Clinical Cases from Taiwan
Wu-Chou, A. I., & Shen, W. W. (2012) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2012.02.004 · Cited by 5
Tolerance to Isoflurane Does Not Occur in Developing Xenopus laevis Tadpoles
Milutinovic, P. S., Zhao, J., & Sonner, J. M. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818ca33e · Cited by 5
Tratamento das epilepsias generalizadas idiopáticas
Betting, L. E., & Guerreiro, C. A. M. (2008) · Journal of Epilepsy and Clinical Neurophysiology · doi:10.1590/s1676-26492008000600004 · Cited by 5
Gaurav, A., Yadav, M. R., Giridhar, R., Gautam, V., & Singh, R. (2009) · Medicinal Chemistry · doi:10.2174/157340609788681494 · Cited by 5
Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome
van der Lei, M. B., & Kooy, R. F. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.2008168 · Cited by 5
Siddique, M., Khan, H. M., Asif, K., Syed, F., Riaz, H., Ashaqu, M. S., Malik, A. R., Asim, F., Raza, M., & Umair, S. (2022) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2022.11.1.35 · Cited by 5
Sakiyama, Y., Saito, M., & Inoue, O. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.02.002 · Cited by 5
Clément, Y., Prut, L., Saurini, F., Mineur, Y. S., Guisquet, A. M. L., Védrine, S., Andres, C. R., Vodjdani, G., & Belzung, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.041 · Cited by 5
Kombinationsbehandlung von Psychotherapie und Pharmakotherapie: Allgemeine Grundlagen
Klein, J. P., Schweiger, U., & Hohagen, F. (2006) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.54.3.155 · Cited by 5
Murray, T. F. (2019) · Wiley eBooks · doi:10.1002/9781119226253.ch2 · Cited by 5
GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders
Madsen, U., Bräuner‐Osborne, H., Greenwood, J. R., Johansen, T. N., Krogsgaard‐Larsen, P., Liljefors, T., Nielsen, M., & Frølund, B. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse019 · Cited by 5
GABACρ1Subunits Form Functional Receptors But Not Functional Synapses in Hippocampal Neurons
Cheng, Q., Burkat, P. M., Kulli, J. C., & Yang, J. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.5.2605 · Cited by 5
Modulators of the GABAA receptor: Novel therapeutic prospects
Thomsen, C., & Ebert, B. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch18 · Cited by 5
Chu, X., Wu, J.-H., Yu, H., Chun-Ge, Liu, Y.-X., Zou, J., & Li, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110317 · Cited by 4
Serrats, J., Vadodaria, K. C., Brubaker, W., Barker‐Haliski, M. L., White, H. S., Evrard, A., Roucard, C., Taylor, E. M., Vanover, K. E., Cunningham, S., et al. (2025) · Epilepsia · doi:10.1111/epi.18340 · Cited by 4
Mother's little helper turned a foe: Alprazolam use, misuse, and abuse
Cardona-Acosta, A. M., Meisser, N., Vardeleon, N. I., Steiner, H., & Bolaños‐Guzmán, C. A. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111137 · Cited by 5
Kosaki, Y., Nishizawa, D., Hasegawa, J., Yoshida, K., Ikeda, K., & Ichinohe, T. (2024) · Molecular Brain · doi:10.1186/s13041-024-01141-2 · Cited by 4
Fischer, L., Paschke, B., Gareis, F., Schumacher, M., Lière, P., Hiergeist, A., Gessner, A., Rupprecht, R., Neumann, I. D., & Bosch, O. J. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110282 · Cited by 4
Extrasynaptic GABAA Receptors: Subunit Composition, Distribution, and Regulation
Fritschy, J., & Panzanelli, P. (2014) · The Receptors · doi:10.1007/978-1-4939-1426-5_2 · Cited by 4
Self-citationShibasaki, M., Ishii, K., Masukawa, D., Ando, K., Ikekubo, Y., Ishikawa, Y., Shibasaki, Y., Mori, T., & Suzuki, T. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.001 · Cited by 4
Wang, X., Song, Z., Huang, D., Gao, H., Wang, Q., & Wang, Z. P. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15027340 · Cited by 4
Neural Control of Cardiac Function
Paterson, D. J., & Coote, J. H. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50013-2 · Cited by 4
GABAB‐ and GABAA‐receptor‐mediated regulation of Up and Down states across development
Kaplanian, A., Vinos, M., & Skaliora, I. (2022) · The Journal of Physiology · doi:10.1113/jp282736 · Cited by 4
Disha, I. J., Hasan, R., Bhuia, M. S., Ansari, S. A., Ansari, I. A., & Islam, M. T. (2024) · ChemistryOpen · doi:10.1002/open.202400290 · Cited by 4
Vinkers, C. H., Korte-Bouws, G. A. H., Toraño, J. S., Mirza, N. R., Nielsen, E. Ø., Ahring, P. K., de Jong, G. J., & Olivier, B. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1752-8 · Cited by 4
Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics
Özsoy, S., Eşel, E., Turan, T., & Kula, M. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.09.003 · Cited by 4
Flunitrazepam–Membrane Binding
Turina, A. V., García, D. A., & Perillo, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00041-8 · Cited by 4
Li, J., Gao, H., Zhang, H., & Lin, W. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2186309 · Cited by 4
Abdulzahir, A., Klein, S., Lor, C., Perkins, M. G., Frelka, A., & Pearce, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065637 · Cited by 4
Medical support of rehabilitation of stroke patients: the role of GABA-ergic drugs
Kostenko, E. G., Гумарович, К. А., Петрова, Л. В., & Ахматовна, Э. М. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-408 · Cited by 4
Jain, A., Rishu, S., & Nidhi, G. (2010) · International Journal of Pharmacy and Life Sciences · Cited by 4
GABAa receptori - molekulski supstrat za razvoj novih anksiolitika
Obradovic, D. I., Savić, M. M., Ugrešić, N. D., & Bokonjić, D. (2003) · Vojnosanitetski pregled · doi:10.2298/vsp0303345o · Cited by 4
Mendelson, W. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00042-6 · Cited by 4
Phosphorylation Site-Specific Antibodies as Research Tools in Studies of Native GABA A Receptors
Jovanovic, J. N. (2006) · Frontiers in neuroscience · doi:10.1201/9780203486283.ch4 · Cited by 4
Neuroprzekaźnik hamujący w plastyczności kory mózgu
Siucińska, E. (2005) · Cited by 4
Wafford, K. A., & Whiting, P. J. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn051 · Cited by 4
Drug treatment of chronic insomnia — dawn at the end of a long night?
Wilson, S. J., & Nutt, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108096605 · Cited by 4
The “Anesthetic Cascade”: Fact or Fiction?
Antkowiak, B. (2005) · Anesthesiology · doi:10.1097/00000542-200510000-00041 · Cited by 4
Modulation of neuronal network activity in the primary motor cortex
Prokic, E. J. (2012) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00016496 · Cited by 4
Benzodiazepines, Age-Related Pharmacological Changes, and Risk of Falls in Older Adults
Ballóková, A. L., & Fialová, D. (2016) · Neuropathology of Drug Addictions and Substance Misuse · doi:10.1016/b978-0-12-800634-4.00033-0 · Cited by 3
Ni, W., Yi, X., Feng, L., Shen, Y., Jiao, J., Cai, Y., Fu, D., Han, Y., Jia, J., & Li, W. (2023) · Trials · doi:10.1186/s13063-023-07739-6 · Cited by 3
Károlyi, B. I., Potor, A., Kapus, G. L., Fodor, L., Bobok, A. Á., Krámos, B., Magdó, I., Bata, I., & Szabó, G. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.129107 · Cited by 3
γ1 GABAAReceptors in Spinal Nociceptive Circuits
Neumann, E., Cramer, T. L. M., Acuña, M. A., Scheurer, L., Beccarini, C., Lüscher, B., Wildner, H., & Zeilhofer, H. U. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0591-24.2024 · Cited by 3
Advances in neuroscience research and big data's analysis on anxiety disorder
Yu, Q., Ruan, M., Chen, Y., & Wang, C. (2024) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1692 · Cited by 3
Zarrindast, M., Ahmadi, H., & Nasehi, M. (2013) · Journal of Experimental and Applied Animal Sciences · doi:10.20454/jeaas.2013.707 · Cited by 3
Papel de las subunidades alfa del receptor GABAA en la regulación de la conducta agresiva
Martín‐López, M., & Navarro, J. F. (2009) · Psiquiatría Biológica · Cited by 3
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.